
News from Have a Go News
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Have a Go News News

Alzheimer's Disease · AustraliaThe authorization in Australia is for adult patients who are Apolipoprotein E-ε4 heterozygotes or non-carriersSee the Story
Lilly's Kisunla (Donanemab) Receives Marketing Authorization in Australia for the Treatment of Early Symptomatic Alzheimer's Disease
39% Center coverage: 28 sources